Labeler
NorthStar RxLLC NDC Codes
NorthStar RxLLC lists 298 finished drug products in the FDA NDC Directory under NDC labeler codes 16714, 72603.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Levothyroxine Sodium, Atomoxetine, Pregabalin, Dasatinib, Doxepin Hydrochloride, Atorvastatin calcium, Nebivolol, lurasidone hydrochloride, Lidocaine hydrochloride, Olmesartan medoxomil, Sacubitril and Valsartan, Midodrine Hydrochloride, Venlafaxine Hydrochloride, Irbesartan, Telmisartan
- Active ingredients
- Levothyroxine sodium, Atomoxetine hydrochloride, Pregabalin, Dasatinib, Doxepin hydrochloride, Atorvastatin calcium trihydrate, Nebivolol hydrochloride, Lurasidone hydrochloride, Lidocaine hydrochloride anhydrous, Olmesartan medoxomil, Sacubitril, Valsartan
- NDC labeler codes
- 16714, 72603
- Strengths (from the 100 most recently listed products)
- Lidocaine hydrochloride anhydrous 10 mg/mL; Lidocaine hydrochloride anhydrous 20 mg/mL; Bupivacaine hydrochloride 5 mg/mL; Thiamine hydrochloride 100 mg/mL; Ticagrelor 60 mg/1; Ticagrelor 90 mg/1; Olmesartan medoxomil 5 mg/1; Olmesartan medoxomil 20 mg/1; Olmesartan medoxomil 40 mg/1; Sacubitril 24 mg/1; Valsartan 26 mg/1; Sacubitril 49 mg/1; Valsartan 51 mg/1; Sacubitril 97 mg/1; Valsartan 103 mg/1; Midodrine hydrochloride 10 mg/1; Midodrine hydrochloride 2.5 mg/1; Midodrine hydrochloride 5 mg/1; Rivaroxaban 2.5 mg/1; Venlafaxine hydrochloride 150 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Capsule, Injection, Solution, Capsule, Extended release, Solution/ drops, Ointment, Solution, Injection, Powder, Lyophilized, For solution, Suppository, Powder, For suspension, Tablet, Delayed release
- Routes
- Oral, Perineural, Infiltration, Intravenous, Topical, Ophthalmic, Epidural, Intracaudal, Intramuscular, Rectal, Subcutaneous
- Drug classes (FDA established)
- Angiotensin 2 Receptor Blocker, l-Thyroxine, Norepinephrine Reuptake Inhibitor, Amide Local Anesthetic, Kinase Inhibitor, HMG-CoA Reductase Inhibitor, beta-Adrenergic Blocker, Tricyclic Antidepressant, Atypical Antipsychotic, Antiarrhythmic, Neprilysin Inhibitor, alpha-Adrenergic Agonist, Serotonin and Norepinephrine Reuptake Inhibitor, Corticosteroid, Glinide, P2Y12 Platelet Inhibitor, Peroxisome Proliferator Receptor alpha Agonist, Osmotic Laxative, alpha-1 Adrenergic Agonist, Factor Xa Inhibitor, Nonsteroidal Anti-inflammatory Drug, Direct Thrombin Inhibitor, Calculi Dissolution Agent, Phosphate Binder, Aminosalicylate, Nucleoside Metabolic Inhibitor, Proteasome Inhibitor, Folate Analog Metabolic Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 146 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Atorvastatin calcium | Atorvastatin calcium trihydrate 40 mg/1 | Tablet, Film coatedOral | 72603-405 | 72603-0405-02 | — |
| Nebivolol | Nebivolol hydrochloride 2.5 mg/1 | TabletOral | 72603-870 | 72603-0870-01 | — |
| Nebivolol | Nebivolol hydrochloride 5 mg/1 | TabletOral | 72603-871 | 72603-0871-0172603-0871-02 | — |
| Nebivolol | Nebivolol hydrochloride 10 mg/1 | TabletOral | 72603-872 | 72603-0872-0172603-0872-02 | — |
| Nebivolol | Nebivolol hydrochloride 20 mg/1 | TabletOral | 72603-873 | 72603-0873-0172603-0873-02 | — |
| Fluocinonide | Fluocinonide .5 mg/mL | SolutionTopical | 72603-703 | 72603-0703-01 | — |
| Doxepin Hydrochloride | Doxepin hydrochloride 10 mg/1 | CapsuleOral | 72603-390 | 72603-0390-01 | — |
| Doxepin Hydrochloride | Doxepin hydrochloride 100 mg/1 | CapsuleOral | 72603-394 | 72603-0394-01 | — |
| Doxepin Hydrochloride | Doxepin hydrochloride 25 mg/1 | CapsuleOral | 72603-391 | 72603-0391-01 | — |
| Doxepin Hydrochloride | Doxepin hydrochloride 50 mg/1 | CapsuleOral | 72603-392 | 72603-0392-01 | — |
| Doxepin Hydrochloride | Doxepin hydrochloride 75 mg/1 | CapsuleOral | 72603-393 | 72603-0393-01 | — |
| lurasidone hydrochloride | Lurasidone hydrochloride 60 mg/1 | Tablet, Film coatedOral | 72603-623 | 72603-0623-01 | — |
| lurasidone hydrochloride | Lurasidone hydrochloride 20 mg/1 | Tablet, Film coatedOral | 72603-621 | 72603-0621-01 | — |
| lurasidone hydrochloride | Lurasidone hydrochloride 40 mg/1 | Tablet, Film coatedOral | 72603-622 | 72603-0622-01 | — |
| lurasidone hydrochloride | Lurasidone hydrochloride 80 mg/1 | Tablet, Film coatedOral | 72603-624 | 72603-0624-01 | — |
| Levothyroxine Sodium | Levothyroxine sodium 88 ug/1 | TabletOral | 72603-663 | 72603-0663-0172603-0663-0272603-0663-11 | — |
| Levothyroxine Sodium | Levothyroxine sodium 25 ug/1 | TabletOral | 72603-660 | 72603-0660-0172603-0660-0272603-0660-11 | — |
| Levothyroxine Sodium | Levothyroxine sodium 50 ug/1 | TabletOral | 72603-661 | 72603-0661-0172603-0661-0272603-0661-11 | — |
| Levothyroxine Sodium | Levothyroxine sodium 75 ug/1 | TabletOral | 72603-662 | 72603-0662-0172603-0662-0272603-0662-11 | — |
| Levothyroxine Sodium | Levothyroxine sodium 137 ug/1 | TabletOral | 72603-667 | 72603-0667-0172603-0667-0272603-0667-11 | — |
| Levothyroxine Sodium | Levothyroxine sodium 100 ug/1 | TabletOral | 72603-664 | 72603-0664-0172603-0664-0272603-0664-11 | — |
| Levothyroxine Sodium | Levothyroxine sodium 112 ug/1 | TabletOral | 72603-665 | 72603-0665-0172603-0665-0272603-0665-11 | — |
| Levothyroxine Sodium | Levothyroxine sodium 125 ug/1 | TabletOral | 72603-666 | 72603-0666-0172603-0666-0272603-0666-11 | — |
| Levothyroxine Sodium | Levothyroxine sodium 150 ug/1 | TabletOral | 72603-668 | 72603-0668-0172603-0668-0272603-0668-11 | — |
| Levothyroxine Sodium | Levothyroxine sodium 175 ug/1 | TabletOral | 72603-669 | 72603-0669-0172603-0669-0272603-0669-11 | — |
| Levothyroxine Sodium | Levothyroxine sodium 200 ug/1 | TabletOral | 72603-701 | 72603-0701-0172603-0701-0272603-0701-11 | — |
| Repaglinide | Repaglinide 2 mg/1 | TabletOral | 72603-812 | 72603-0812-01 | — |
| Repaglinide | Repaglinide .5 mg/1 | TabletOral | 72603-810 | 72603-0810-01 | — |
| Repaglinide | Repaglinide 1 mg/1 | TabletOral | 72603-811 | 72603-0811-01 | — |
| Triamcinolone acetonide | Triamcinolone acetonide 1 mg/g | OintmentTopical | 16714-276 | 16714-0276-0116714-0276-0216714-0276-03 | — |
| Sodium sulfate, potassium sulfate and magnesium sulfate | Sodium sulfate 17.5 g/177mL + 2 more ingredients | SolutionOral | 72603-278 | 72603-0278-02 | — |
| Lidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionInfiltration, Perineural | 72603-722 | 72603-0722-25 | — |
| Lidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionInfiltration, Perineural | 72603-732 | 72603-0732-25 | — |
| Lidocaine hydrochloride | Lidocaine hydrochloride anhydrous 20 mg/mL | Injection, SolutionInfiltration, Perineural | 72603-744 | 72603-0744-25 | — |
| Lidocaine hydrochloride | Lidocaine hydrochloride anhydrous 20 mg/mL | Injection, SolutionInfiltration, Perineural | 72603-825 | 72603-0825-1072603-0825-25 | — |
| Candesartan | Candesartan cilexetil 16 mg/1 | TabletOral | 72603-720 | 72603-0720-01 | — |
| Candesartan | Candesartan cilexetil 32 mg/1 | TabletOral | 72603-721 | 72603-0721-01 | — |
| Sevelamer Carbonate | Sevelamer carbonate .8 g/1 | Powder, For suspensionOral | 72603-398 | 72603-0398-02 | — |
| timolol maleate | Timolol maleate 5 mg/mL | Solution/ dropsOphthalmic | 72603-540 | 72603-0540-01 | — |
| pitavastatin calcium | Pitavastatin calcium 2.09 mg/1 | Tablet, Film coatedOral | 72603-479 | 72603-0479-01 | — |
| pitavastatin calcium | Pitavastatin calcium 4.18 mg/1 | Tablet, Film coatedOral | 72603-480 | 72603-0480-01 | — |
| Mesalamine | Mesalamine 1.2 g/1 | Tablet, Delayed releaseOral | 72603-304 | 72603-0304-01 | — |
| capecitabine | Capecitabine 500 mg/1 | Tablet, Film coatedOral | 72603-303 | 72603-0303-01 | — |
| Bortezomib | Bortezomib 3.5 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous, Subcutaneous | 72603-270 | 72603-0270-01 | — |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 2.5 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | 72603-415 | 72603-0415-25 | — |
| Pemetrexedpemetrexed disodium | Pemetrexed disodium hemipentahydrate 500 mg/50mL | Injection, Powder, Lyophilized, For solutionIntravenous | 72603-425 | 72603-0425-01 | — |
| Phenylephrine Hydrochloride | Phenylephrine hydrochloride 100 mg/mL | Solution/ dropsOphthalmic | 72603-530 | 72603-0530-01 | — |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 5 mg/mL | Injection, SolutionEpidural, Intracaudal, Perineural | 72603-506 | 72603-0506-1072603-0506-25 | — |
| Phenylephrine Hydrochloride | Phenylephrine hydrochloride 25 mg/mL | Solution/ dropsOphthalmic | 72603-520 | 72603-0520-0172603-0520-02 | — |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 5 mg/mL | Injection, SolutionEpidural, Intracaudal, Perineural | 72603-602 | 72603-0602-25 | — |
NorthStar RxLLC: common questions
- What is NorthStar RxLLC's NDC labeler code?
- 16714, 72603. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for NorthStar RxLLC?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.